Aging-US

Aging Podcast

Aging is dedicated to advancing our understanding of the biological mechanisms that drive aging and the development of age-related diseases. Our mission is to serve as a platform for high-quality research that uncovers the cellular, molecular, and systemic processes underlying aging, and translates these insights into strategies to extend healthspan and delay the onset of chronic disease. Read about the Aging Scientific Integrity Process: https://aging-us.com/scientific-integrity

  1. 1d ago

    Albumin Protein Modifications Highlight Midlife Transition in Molecular Aging

    BUFFALO, NY — November 19, 2026 — A new #research paper was #published in Volume 18 of Aging on November 4, 2026, titled “Age-dependent albumin post-translational modification landscape reveals a critical midlife transition window.” The study examines how age-related changes in albumin, the most abundant protein in human blood plasma, may reflect biological aging. Researchers identified distinct patterns of protein modifications that change throughout adulthood, with a particularly important transition occurring between ages 50 and 60. The study's first author is Meng Han, affiliated with the School of Life Sciences, Tsinghua University, Beijing, China. The corresponding authors are Yuling Chen and Haiteng Deng, both affiliated with the same institution. Deng is also affiliated with the Yangtze Delta Region Institute of Tsinghua University in Jiaxing, China. Albumin plays several essential roles in the body, including transporting substances through the bloodstream, maintaining fluid balance and protecting tissues against oxidative stress. As people age, both the amount of albumin and its chemical modifications can change, potentially affecting its biological functions. These changes often involve post-translational modifications, chemical alterations that occur after a protein is produced. Processes such as oxidation and glycation can influence protein stability and activity, making them potential indicators of age-related biological changes. To investigate these patterns, researchers analyzed plasma samples from 133 healthy individuals across four age groups, ranging from younger than 40 to older than 70 years. They first developed a protein-based aging model and identified albumin as the strongest individual contributor to age prediction. Full press release - https://www.aging-us.com/news-room/albumin-protein-modifications-highlight-midlife-transition-in-molecular-aging DOI - https://doi.org/10.18632/aging.206435 Corresponding authors - Yuling Chen - chenyuling2016@mail.tsinghua.edu.cn, and Haiteng Deng - dht@mail.tsinghua.edu.cn Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206435 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, aging clock, albumin, PTM dynamics, cys34 oxidation, C-terminal degradation To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    Albumin Protein Modifications Highlight Midlife Transition in Molecular Aging
  2. 2d ago

    The Future of Aging Research: Scientists and Biotech Leaders Explore Next Frontier of Longevity

    The Future of Aging Research (FAR) Mixer 2026, brought together prominent researchers, biotechnology founders, and industry leaders for discussions on the future of longevity science. The event explored how advances in artificial intelligence (AI), genomics, immunology, and therapeutic development are creating new opportunities to understand biological aging and translate scientific discoveries into interventions that improve human health. Speakers included Moderna and Soufflé Therapeutics cofounder Robert Langer, ScD; Tolerance Bio CEO Francisco Leon, PhD; MIT and Broad Institute researcher Manolis Kellis; cardiovascular researcher and Director of Cardiac MRI at Beth Israel Deaconess Medical Center (BIDMC) Connie Tsao, MD; and Retro Biosciences founder and CEO Joe Betts-Lacroix. A panel featuring representatives from Pfizer, Flagship Pioneering, and Loyal examined the biotechnology and biopharmaceutical industry’s evolving approach to targeting aging. Across the presentations and discussions, several themes emerged: the importance of understanding the biological mechanisms underlying aging, the potential of AI to accelerate therapeutic discovery, the need for better measures of healthspan, and the growing role of biotechnology companies in translating research into clinical applications. Full mixer recap - https://aging-us.org/2026/11/the-future-of-aging-research-scientists-and-biotech-leaders-explore-next-frontier-of-longevity/ Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    The Future of Aging Research: Scientists and Biotech Leaders Explore Next Frontier of Longevity
  3. 3d ago

    Blood-Brain Barrier Dysfunction Linked to Altered Brain Metabolism in Alzheimer’s Disease

    BUFFALO, NY — November 17, 2026 — A new #research paper was #published in Volume 18 of Aging on November 3, 2026, titled “Brain glucose metabolism and blood-brain barrier permeability in Alzheimer’s disease continuum.” The study examines the relationship between blood-brain barrier integrity and brain glucose metabolism in Alzheimer’s disease. Researchers found that patients with different Alzheimer’s biomarker profiles showed similar patterns of reduced brain metabolism, but the biological factors associated with these changes differed between groups. The study’s first author is Francesco Ricci, affiliated with the the Non Invasive Brain Stimulation Unit at IRCCS Santa Lucia and the Dementia Center at Policlinico Tor Vergata, University of Rome Tor Vergata, Italy. The corresponding author is Alessandro Martorana, affiliated with the Dementia Center at Policlinico Tor Vergata, University of Rome Tor Vergata, Italy. Alzheimer’s disease is characterized by the accumulation of amyloid-beta and tau proteins in the brain, which contribute to neuronal dysfunction and cognitive decline. However, not all patients show the same biological patterns, suggesting that different mechanisms may contribute to disease progression. The blood-brain barrier is a protective system that regulates the movement of substances between the bloodstream and brain tissue. When its function is impaired, changes in vascular permeability and the brain’s internal environment may affect neuronal health and glucose metabolism. To investigate these relationships, researchers analyzed 66 patients along the Alzheimer’s disease continuum and 41 cognitively healthy controls. The patients were divided into two groups based on biomarkers of amyloid accumulation, tau pathology and neurodegeneration. One group showed evidence of all three abnormalities, while the other had amyloid pathology and neurodegeneration without elevated phosphorylated tau. Full press release - https://www.aging-us.com/news-room/blood-brain-barrier-dysfunction-linked-to-altered-brain-metabolism-in-alzheimers-disease DOI - https://doi.org/10.18632/aging.206393 Corresponding author - Alessandro Martorana - martorana@med.uniroma2.it Abstract video - https://www.youtube.com/watch?v=pPVIGcjWhqg Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206393 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, Alzheimer’s disease continuum, AD biomarkers, blood-brain-barrier, brain metabolism, FDG-PET To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    Blood-Brain Barrier Dysfunction Linked to Altered Brain Metabolism in Alzheimer’s Disease
  4. Nov 13

    Editors’ Choice: Investigating the efficacy and toxicity of partial in vivo reprogramming as a rejuvenation intervention

    Each month, we will highlight a paper published in Aging chosen as the “Editors’ Choice.” These selections are handpicked by our editors and accompanied by a brief summary, showcasing research with significant impact and novel insights in aging and age-related diseases. __________ This month’s Editors’ Choice, “Investigating the efficacy and toxicity of partial in vivo reprogramming as a rejuvenation intervention,” examines the potential benefits and risks of partial cellular reprogramming as an approach to rejuvenation. Analyzing gene expression data from the liver, kidney, and spleen of aged mice, the researchers identified tissue-specific responses, including reduced age-related inflammation and improved metabolic pathway activity in the liver and kidney. However, findings in the spleen suggested increased cellular proliferation and potential genomic stress, highlighting important safety considerations. This study underscores the need for further research to better understand the long-term effects and safety of partial reprogramming as a potential aging intervention. DOI - https://doi.org/10.18632/aging.206431 Corresponding author - Franziska Meiners - franziska.meiners@uni-rostock.de Abstract video - https://www.youtube.com/watch?v=hH518dZDq88 Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206431 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, partial reprogramming, rejuvenation, adverse outcome pathways, metabolism To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    Editors’ Choice: Investigating the efficacy and toxicity of partial in vivo reprogramming as a rejuvenation intervention
  5. Nov 12

    Partial Reprogramming Linked to Tissue-Specific Rejuvenation Signals and Potential Risks

    BUFFALO, NY — November 12, 2026 — A new #research paper was #published in Volume 18 of Aging on October 27, 2026, titled “Investigating the efficacy and toxicity of partial in vivo reprogramming as a rejuvenation intervention.” The study examines how partial cellular reprogramming, an experimental approach aimed at reversing certain age-related changes, affects different organs. Researchers found potentially beneficial molecular changes in the liver and kidneys of aged mice, alongside signals in the spleen that raise concerns about the intervention’s long-term safety. The paper’s first and corresponding author is Franziska Meiners, affiliated with the Institute for Biostatistics and Informatics in Medicine and Ageing Research at University Medical Center Rostock, Germany. Partial reprogramming has emerged as a potential rejuvenation strategy by temporarily activating proteins known as Yamanaka factors. These proteins can alter gene activity and may help restore some youthful cellular characteristics. However, concerns remain about possible adverse effects, including uncontrolled cell proliferation and genomic instability. To investigate these effects, the researchers reanalyzed previously published gene-expression data from the liver, kidneys and spleen of aged mice that had undergone seven months of partial reprogramming. They used the Adverse Outcome Pathway framework to examine molecular changes associated with potential benefits and risks. The analysis revealed different responses across the three organs. In the liver and kidneys, partial reprogramming was associated with reduced expression of inflammation-related genes and increased expression of genes involved in metabolic pathways that typically decline with age. Full press release - https://www.aging-us.com/news-room/partial-reprogramming-linked-to-tissue-specific-rejuvenation-signals-and-potential-risks DOI - https://doi.org/10.18632/aging.206431 Corresponding author - Franziska Meiners - franziska.meiners@uni-rostock.de Abstract video - https://www.youtube.com/watch?v=hH518dZDq88 Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206431 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, partial reprogramming, rejuvenation, adverse outcome pathways, metabolism To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    Partial Reprogramming Linked to Tissue-Specific Rejuvenation Signals and Potential Risks
  6. Nov 10

    New Aging Framework Shifts Focus of Late-Life Rejuvenation to Systemic Signaling

    BUFFALO, NY — November 10, 2026 — A new #research perspective was #published in Volume 18 of Aging on October 20, 2026, titled “From hyperfunction to systemic amplification: reframing the logic of late-life rejuvenation.” The paper proposes a new framework for understanding why aging accelerates later in life and how future rejuvenation strategies could address this decline. Rather than focusing only on molecular damage accumulating within individual cells, the author suggests that communication between cells and organs plays a central role in amplifying age-related changes throughout the body. The research perspective was authored by Pierre-Edouard Sottas, who is affiliated with the xLongevity Center in Vevey, Switzerland. Aging is commonly understood as the gradual accumulation of cellular damage, including DNA alterations, mitochondrial dysfunction and changes in gene regulation. However, this explanation does not fully account for why functional decline and mortality risk often accelerate sharply in later life. Building on the hyperfunction theory developed by Mikhail Blagosklonny, the paper explores how biological processes that support growth, repair and survival earlier in life can become harmful when their activity persists or becomes excessive. Sottas introduces an integrative-first load–gain framework that distinguishes between two components of aging. The first, known as the damage load, represents molecular damage that gradually accumulates within cells. The second, systemic gain, describes how communication networks throughout the body can amplify the effects of that damage. According to the proposed framework, inflammatory signals, immune and hormonal changes, and extracellular vesicles can spread stress-related messages between cells and tissues. When these signals become persistent and self-reinforcing, they could contribute to the accelerated decline associated with advanced age. The perspective draws on research involving plasma exchange, extracellular vesicle-based interventions and cellular reprogramming to explore how changes in the body’s internal environment can influence aging-related processes across multiple tissues. Full press release - https://www.aging-us.com/news-room/new-aging-framework-shifts-focus-of-late-life-rejuvenation-to-systemic-signaling DOI - https://doi.org/10.18632/aging.206430 Corresponding author - Pierre-Edouard Sottas - pes@xlongevity.com Abstract video - https://www.youtube.com/watch?v=70YD8siv7Yc Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206430 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, hyperfunction, antagonistic pleiotropy, systemic amplification, Gompertzian mortality, senescence-associated signaling To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    New Aging Framework Shifts Focus of Late-Life Rejuvenation to Systemic Signaling
  7. Nov 9

    Epigenetic Aging Signal Is Linked to Brain Changes Associated With Dementia Risk

    Two people can be the same chronological age and yet differ considerably in how quickly their bodies appear to be aging. Scientists have developed “epigenetic clocks” that use chemical changes to DNA to estimate aspects of biological aging. But whether an older biological age measured in blood also means that the brain is aging faster has remained unclear. A research paper published in Volume 18 of Aging titled “Association of epigenetic age acceleration with MRI biomarkers of aging and Alzheimer’s disease neurodegeneration,” investigated that question in 1,196 older women. The study was led by first and corresponding author Linda K. McEvoy of the Kaiser Permanente Washington Health Research Institute. The researchers compared five widely used epigenetic aging measures with structural MRI scans obtained an average of about eight years later. None of the five clocks was associated with a general measure of accelerated brain aging. One clock, however—GrimAge2—was associated with an MRI pattern linked to greater dementia risk. A closer look suggested that this relationship was largely connected to an epigenetic signature of smoking exposure and to lower volumes in the frontal and temporal regions of the brain, rather than to the hippocampus and entorhinal cortex, which are strongly implicated in early Alzheimer’s disease. The findings suggest that biological aging cannot necessarily be reduced to a single number. A blood-based aging measure may capture important health-related processes without directly reflecting how old the brain appears on MRI. Full blog post - https://aging-us.org/2026/11/epigenetic-aging-signal-is-linked-to-brain-changes-associated-with-dementia-risk/ DOI - https://doi.org/10.18632/aging.206369 Corresponding author - Linda K. McEvoy - linda.k.mcevoy@kp.org Abstract video - https://www.youtube.com/watch?v=kZiRjlKnnsI Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206369 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, epigenetic clocks, brain age, biological aging, smoking, frontal lobe To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    Epigenetic Aging Signal Is Linked to Brain Changes Associated With Dementia Risk
  8. Nov 5

    Ferroptosis-Related Genes in Muscular Dystrophy May Offer New Insights Into Muscle Aging

    BUFFALO, NY — November 5, 2026 — A new #research paper was #published in Volume 18 of Aging on October 14, 2026, titled “Ferroptosis-related hub genes and immune infiltration characteristics in Duchenne muscular dystrophy: a molecular framework with implications for aging-related muscle degeneration.” The study identified three genes associated with ferroptosis, an iron-dependent form of cell death, and changes in immune-related signals in Duchenne muscular dystrophy (DMD). By analyzing human muscle gene-expression data and conducting experiments in mice, the researchers identified molecular characteristics that may also be relevant to age-related muscle degeneration. The findings offer new insights into potential connections between iron metabolism, inflammation and muscle health. The research was led by equal-contributing first authors Juanjuan Peng, affiliated with Nanjing University of Chinese Medicine, and Jing Hu, affiliated with Nanjing Jiangning Hospital of Chinese Medicine. Corresponding author Houxi Xu is affiliated with the Nanjing University of Chinese Medicine. Age-related muscle loss, known as sarcopenia, is a major contributor to frailty, disability and declining independence in older adults. Although its causes are complex, growing evidence suggests that iron accumulation, oxidative stress, inflammation and impaired muscle regeneration may contribute to progressive muscle deterioration. One emerging mechanism is ferroptosis, a form of regulated cell death caused by iron-dependent oxidative damage to cellular membranes. Researchers are increasingly investigating whether this process contributes to muscle degeneration and whether understanding its regulation could reveal new approaches to preserving muscle function. Duchenne muscular dystrophy, a genetic disorder that causes progressive muscle weakness, shares certain pathological features with aging-related muscle degeneration. These include oxidative stress, chronic inflammation and reduced regenerative capacity. Although DMD is distinct from normal aging, these similarities provide an opportunity to investigate potentially shared molecular pathways. To explore these connections, the researchers analyzed two publicly available human DMD datasets containing 33 muscle samples from patients with DMD and 12 healthy controls. They identified 35 ferroptosis-related genes showing altered expression, with three emerging as particularly important: HIF1A, CDKN1A and CD44. Full press release - https://www.aging-us.com/news-room/ferroptosis-related-genes-in-muscular-dystrophy-may-offer-new-insights-into-muscle-aging DOI - https://doi.org/10.18632/aging.206429 Corresponding author - Houxi Xu - xuhouxi@njucm.edu.cn Abstract video - https://www.youtube.com/watch?v=VlouLQYO4I8 Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206429 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, sarcopenia, ferroptosis, inflammaging, muscle degeneration To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

    Ferroptosis-Related Genes in Muscular Dystrophy May Offer New Insights Into Muscle Aging

Ratings & Reviews

4
out of 5
2 Ratings

About

Aging is dedicated to advancing our understanding of the biological mechanisms that drive aging and the development of age-related diseases. Our mission is to serve as a platform for high-quality research that uncovers the cellular, molecular, and systemic processes underlying aging, and translates these insights into strategies to extend healthspan and delay the onset of chronic disease. Read about the Aging Scientific Integrity Process: https://aging-us.com/scientific-integrity